Rigel Pharmaceuticals | RIGL - Ebitda





Ebitda Değişiklik Tarih
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.67B 1.29B 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celldex Therapeutics USD -86.34M 13.54M 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 12.14B 4.26B 2025-12
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pfizer USD 756M 5.32B 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Veracyte USD 42.31M 2.58M 2025-12